Navigation Links
BioSpecifics Announces Partnership Between Auxilium and Actelion for XIAFLEX® in Canada, Australia, Brazil and Mexico
Date:2/23/2012

lion in potential sales milestone payments. BioSpecifics will also receive royalties from net sales and payments on costs of goods sold in Actelion's territories from Auxilium, which will be a specified percentage of what Auxilium receives from Actelion.

Actelion is a Swiss biopharmaceutical company with $2.0B in 2011 worldwide sales in 2011 and over 2,500 employees focused on the discovery, development and marketing of innovative drugs for significant unmet medical needs. Actelion shares are traded on the SIX Swiss Exchange (ticker symbol: ATLN) as part of the Swiss blue-chip index SMI (Swiss Market Index SMI®).

About Dupuytren's Contracture

Dupuytren's contracture is caused by an abnormal accumulation of collagen in the palm of the hand characterized by the formation of nodules or lumps in the early stages. As the disease progresses, a cord is formed and the fingers may become progressively contracted.

About Peyronie's Disease

Peyronie's disease is characterized by the presence of inelastic collagen on the shaft of the penis, which can distort an erection and make sexual intercourse difficult or impossible in advanced cases. Significant psychological distress is common among sexually active patients with Peyronie's disease. Currently, there are no FDA approved pharmaceutical therapies for this disease.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications. Its partner Auxilium Pharmaceuticals, Inc. markets XIAFLEX® in the U.S. for the treatment of Dupuytren's contracture in adults with palpable cord in the palm and is also developing XIAFLEX for the treatment of Peyronie's disease, which is currently in Phase 3 pivotal clinical trials, as well as for Frozen Shoulder (Adhesive Capsulitis) and cellulite. Pfizer, Inc. is responsible for marketing XIAPEX® for Dup
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 8th Annual Healthcare Conference
2. Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
3. BioSpecifics Technologies Corp. Reports Second Quarter 2011 Financial Results
4. BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase Program
5. BioSpecifics Technologies Corp. to Present at Jefferies 2011 Global Healthcare Conference
6. BioSpecifics Announces Positive XIAPEX® Data Presented at XVI Annual Federation of European Societies for Surgery of the Hand Congress
7. BioSpecifics Technologies Corp. Provides Update on XIAPEX® Launch Progress in EU
8. BioSpecifics Technologies Corp. to Present at SEVEN, Noble Financial Capital Markets Seventh Annual Equity Conference
9. BioSpecifics Technologies Corp. Announces Launch of XIAPEX® by Pfizer for Treatment of Dupuytrens Contracture in Europe
10. BioSpecifics Technologies Corp. to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference
11. BioSpecifics Technologies Corp. Amends Its Rights Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014  Dr. Mark Rasak , MD ... Lifetime Achievement Award in the field of Medicine as ... Clinical Associates. Dr. Rasak has over 15 ... aspects of the business; overseeing the daily operations; interventional ... intervention. In addition, he is an honored Fellow of ...
(Date:8/22/2014)... Research and Markets has announced the addition ... Report 2014" report to their offering. ... 2014 is a professional and in-depth study on the ... a focus on the Chinese situation. The report ... classifications, applications and industry chain structure. The intravenous catheter ...
(Date:8/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The particulate ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Global and Chinese Intravenous Catheter Industry Report 2014 2Global and Chinese Particulate Respirators Industry Report 2014 2
... Ind., Aug. 18, 2011 Symmetry Medical Inc. (NYSE: ... innovative medical device solutions, including orthopedic implants, surgical instruments, ... has completed the previously announced acquisition of Olsen Medical. ... in the design, development and manufacturing of electrosurgical instruments ...
... 18, 2011 According to the Arthritis ... in the United States and is one of the ... Pet owners can easily be overwhelmed by the variety ... symptoms. NationalPetPharmacy.com provides the following nutritional recommendations ...
Cached Medicine Technology:Symmetry Medical Closes Olsen Medical Acquisition 2Tips for Reducing the Signs of Arthritis in Pets 2Tips for Reducing the Signs of Arthritis in Pets 3
(Date:8/22/2014)... HealthDay Reporter FRIDAY, Aug. ... Americans on work disability chronically use powerful prescription painkillers, ... between 2007 and 2011, about 44 percent of people ... painkillers each year. And the percentage using the drugs ... percent in 2011. Experts said the trend ...
(Date:8/22/2014)... 22, 2014 Millennium Treatment Group, ... Lantana, FL, recently launched a new website. Patients, ... information can now find Millennium Treatment Group at ... went live at the beginning of July. Everything ... can be found on the website. There’s an ...
(Date:8/22/2014)... oncogenic somatic mutation at amino acid 918 in the ... small cell lung cancer (SCLC) tumors and enforced expression ... intracellular signaling and cell growth. , SCLC is a ... all lung cancers and is strongly associated with tobacco ... extensively examined for genomic alterations and targeted therapies are ...
(Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... more magnetic for some clinical applications due to ... of the emerging innovations in ultrasound, such as ... imaging, are expected to keep the market moving ... as increasing mobility can enhance not only the ...
(Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... the recent past, specifically in the developing world, has ... infection and the number of deaths due to AIDS ... are declining, the number of new patients becoming affected ... the conscious efforts being undertaken by all related organisations ...
Breaking Medicine News(10 mins):Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Millennium Treatment Group Has a New Website 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3
... greater impact on health than outdoor air quality, as ... indoors. Exposure to chemical and biological contaminants and possible ... risk of developing respiratory and neurologic symptoms, allergies, asthma ... of Ottawa; the Environmental Health Sciences Bureau (Canada); the ...
... make the habit more likely, study finds , , MONDAY, July ... easily on cigarettes -- say from friends or close acquaintances ... smoking habit, a new study of sixth-graders finds. , Hopefully, ... before they even start, said the authors of ...
... U.S. by 2050 , , MONDAY, July 14 (HealthDay News) -- ... boost kidney stone rates in the United States and around ... in particular, hotter weather will lead to a dramatic rise ... the so-called "kidney-stone belt." This will result in an increase ...
... Medical Device,Manufacturers Association (MDMA), a national trade association ... Board of Directors at the,MDMA Annual Meeting held ... ), "I am honored to serve ... stated Root. "MDMA has a long history of ...
... Nets star Josh Boone and 50 local students, WHAT: To ... program, the Nets will conduct a fitness clinic to encourage ... drinking milk, ... Josh Boone,s week long basketball camp., WHY: ...
... report lower quality of life, poorer outlook , , MONDAY, July ... a person,s outlook on life, a new government study finds. ... lower on four scales measuring their quality of life, according ... Circulation , from researchers at the U.S. Centers for Disease ...
Cached Medicine News:Health News:Access Is Key to Kids' Decision to Smoke 2Health News:Global Warming Linked to Heightened Kidney Stone Risk 2Health News:Global Warming Linked to Heightened Kidney Stone Risk 3Health News:Vascular Solutions CEO Elected to MDMA Board of Directors 2Health News:Coronary Heart Disease Not a Cheery Condition 2Health News:Coronary Heart Disease Not a Cheery Condition 3
... For use in the percutaneous retrieval of indwelling ... wire guides, and other foreign objects. A ... around the lead body. It is delivered to ... flexible 12 Fr cannula that is placed coaxially ...
... Novalis, BrainLAB's dedicated ... radiosurgery and radiotherapy (SRS/SRT), ... highly precise treatments of ... head & neck tumors, ...
The Radionics XKnife RT2 system provides a precise and versatile stereotactic radiation therapy solution....
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: